NL7112971A - - Google Patents

Info

Publication number
NL7112971A
NL7112971A NL7112971A NL7112971A NL7112971A NL 7112971 A NL7112971 A NL 7112971A NL 7112971 A NL7112971 A NL 7112971A NL 7112971 A NL7112971 A NL 7112971A NL 7112971 A NL7112971 A NL 7112971A
Authority
NL
Netherlands
Application number
NL7112971A
Other versions
NL145553B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7034133A external-priority patent/FR2105060A1/en
Priority claimed from FR7130825A external-priority patent/FR2150236A2/en
Application filed filed Critical
Publication of NL7112971A publication Critical patent/NL7112971A/xx
Publication of NL145553B publication Critical patent/NL145553B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL717112971A 1970-09-21 1971-09-21 PROCESS FOR PREPARING IMIDAZOLYLCARBAMIC ACID DERIVATIVES, PROCESS FOR PREPARING ANTHELMINTIC ACTIVE PREPARATIONS AND FORMED PREPARATIONS. NL145553B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7034133A FR2105060A1 (en) 1970-09-21 1970-09-21 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Publications (2)

Publication Number Publication Date
NL7112971A true NL7112971A (en) 1972-03-23
NL145553B NL145553B (en) 1975-04-15

Family

ID=26215952

Family Applications (1)

Application Number Title Priority Date Filing Date
NL717112971A NL145553B (en) 1970-09-21 1971-09-21 PROCESS FOR PREPARING IMIDAZOLYLCARBAMIC ACID DERIVATIVES, PROCESS FOR PREPARING ANTHELMINTIC ACTIVE PREPARATIONS AND FORMED PREPARATIONS.

Country Status (13)

Country Link
AU (1) AU453067B2 (en)
BE (1) BE772835A (en)
CA (1) CA940131A (en)
CH (1) CH532600A (en)
DE (1) DE2147103C3 (en)
DK (1) DK131345B (en)
ES (2) ES395260A1 (en)
GB (1) GB1318859A (en)
HU (1) HU163150B (en)
IL (1) IL37752A (en)
LU (1) LU63927A1 (en)
NL (1) NL145553B (en)
SE (1) SE368828B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60021065T2 (en) 1999-03-31 2006-06-01 UAF Technologies and Research, LLC, Tucson VIRUS TREATMENT
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
ES395260A1 (en) 1973-12-01
LU63927A1 (en) 1972-06-27
AU453067B2 (en) 1974-09-19
IL37752A0 (en) 1971-11-29
IL37752A (en) 1974-10-22
DK131345B (en) 1975-06-30
DK131345C (en) 1975-11-24
NL145553B (en) 1975-04-15
SE368828B (en) 1974-07-22
GB1318859A (en) 1973-05-31
CH532600A (en) 1973-01-15
HU163150B (en) 1973-06-28
DE2147103B2 (en) 1974-11-14
CA940131A (en) 1974-01-15
ES403910A1 (en) 1975-05-01
BE772835A (en) 1972-03-20
AU3373571A (en) 1973-03-29
DE2147103C3 (en) 1975-07-17
DE2147103A1 (en) 1972-03-23

Similar Documents

Publication Publication Date Title
AR204384A1 (en)
ATA96471A (en)
AU2044470A (en)
AU1473870A (en)
AU1146470A (en)
AU1326870A (en)
AU2085370A (en)
AU2017870A (en)
AU1833270A (en)
AU1716970A (en)
AU1517670A (en)
AU1336970A (en)
AU1591370A (en)
ATA672271A (en)
AU1277070A (en)
AU2144270A (en)
AU1235770A (en)
AU1328670A (en)
AU1189670A (en)
AU1343870A (en)
AU1943370A (en)
AU2130770A (en)
AU2130570A (en)
AU1581370A (en)
AU1974970A (en)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application